A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder

• Status: Unknown status
• Trial end date: 2013-04-01
• Target enrollment: 0
• Participant gender: All

Summary

It's a double blind, placebo controlled study to assess the efficacy of Propantheline Bromide to treat overactive bladder (OAB) in HTLV 1 infected patients.

We think that the treatment of the OAB with Propantheline could reduce nocturia and frequency in sixty percent.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital Universitário Professor Edgard Santos
• Treatments: Bromides; Propantheline

Criteria

Inclusion Criteria:

• HTLV-1 infection

• More than 18 years

• Negative urine culture

• No neurological damage

Exclusion Criteria:

• Diabetes

• Persistently positive urine culture

• Pelvic, head, urological or gynecological surgery

• Stroke